GEN - Genetic Engineering and Biotechnology News6h
StockWatch: Will Trump Tariffs Return Biopharma Manufacturing to the U.S.?
With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...
KHQA on MSN8h
Quincy High students excel at regional science fair, eight projects advance to state
Quincy High School’s Science Research Class and Club excelled at the Regional Science Fair on March 22, with eight out of ...
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $130,880.12 today based ...
Regeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease Treatment
Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...
The Manila Times15h
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology ...
Intellia: Nex-Z Advancement Remains On Track With Expanded ATTRv-PN Indication
CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.
PharmiWeb17h
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...
Regeneron, Sanofi announce Dupixent authorization in Japan
Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing ...
Putnam Large Cap Value Fund Q4 2024 Commentary
While US stocks overall posted a gain in the fourth quarter, value stocks fared differently, posting a modest negative return ...